$PG

Evercore Upgrades Procter & Gamble (PG) to Outperform with Raise

Evercore ISI upgraded Procter & Gamble (PG) to Outperform, raising its price target to $166. The firm cited improved U.S. execution, stabilizing category volumes, and positive reorganization outcomes. PG's fiscal first-quarter organic sales growth forecast was lifted to 3%, surpassing consensus estimates. The company offers a 2.84% dividend yield with a 61% payout ratio, and GuruFocus rates it modestly undervalued.

Original reporting
Published Oct 10, 2026, 2:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 11, 2026, 4:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PG
Bullish
medium confidence
Mentioned
$PG
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$PGBullishMed
01

Why it matters

The upgrade may trigger buying interest and support the stock's price, especially ahead of the market open.

02

Market read

A fresh analyst upgrade for a large-cap consumer staple can move the stock and influence sector sentiment.

03

What to watch

The dividend yield of 2.84% and 5% annual growth may attract income investors, adding a different driver beyond the upgrade.

Relevance 7/10Novelty 6/10Timing: pre‑market today

Background

Evercore ISI raised its outlook on Procter & Gamble, citing better U.S. execution, stabilizing volumes, and reorganization benefits.

Company-level read

Ticker impact

$PGBullishMedium confidence
Context

Evercore ISI upgraded Procter & Gamble (PG) to Outperform and raised the price target to $166 from $161.

Expected impact

likely upward pressure as the market prices in the higher target

Evidence & confidence

The new target and Outperform rating reflect fresh analyst confidence, which typically drives buying interest.

Market effects

Consumer defensive stocks may benefit from the positive outlook on P&G's execution and sales growth.

U.S. equity markets could see modest buying pressure in consumer staples.

Limited to markets with exposure to P&G; no broad global effect.

Counterpoint

Insider selling of $63M in the past year could signal concerns despite the upgrade.

Key entities

  • Procter & Gamble Co

    Consumer packaged goods giant receiving the upgrade.

  • Evercore ISI

    Research firm issuing the Outperform rating and new price target.

Related articles

$PGHigh

Procter & Gamble could face new cost problem

Procter & Gamble (PG) shares rose 1.5-2% after Evercore ISI upgraded it to Outperform with a $166 price target, citing improved market share and cost pressures. Evercore had been cautious due to PG's underperformance on Amazon and rising costs from oil, shipping, and tariffs, which squeezed margins. The upgrade suggests a 14% upside from the previous close.

$PGHigh

Procter & Gamble could face new cost problem amid oil, shipping, tariff pressures

Procter & Gamble (PG) shares rose 1.5%-2% after Evercore ISI upgraded it to Outperform with a $166 price target, citing improved e-commerce performance and higher sales growth estimates. The firm had previously been cautious due to cost pressures from oil, shipping, and tariffs, but now expects PG to stop losing U.S. e-commerce market share and achieve 4% sales growth by fiscal 2027. PG's dividend yield is 2.9%, and the company has increased its dividend for 70 consecutive years.

$PGLow

Access Proposal at Procter & Gamble

Institutional Shareholder Services (ISS) recommended Procter & Gamble (P&G) shareholders vote 'for' a proposal opposed by the company's board. The proposal, brought by the National Legal and Policy Center (NLPC), aims to preserve shareholder access rights. P&G argues the vote is premature, as the SEC has proposed repealing the rule enabling such proposals. The vote is scheduled for October 13.

$LENHighAI 8/10

Stocks making the biggest moves premarket: Constellation Energy, Option Care Health, Lennar, P&G and more

Constellation Energy (CEG) surged 6% after Google's $4.3B power agreement. Option Care Health (OPK) rose 20% on potential $5B acquisition by McKesson (MCK) and Clayton Dubilier. Lennar (LEN) gained 1.5% after Berkshire Hathaway (BRK.A) disclosed a 2.4M share purchase. NeoGenomics (NEO) climbed 5% on revenue beat and succession plan. AMD (AMD) rose 2% on Citi's $800 price target. P&G (PG) up 1.2% after Evercore ISI upgrade. Corteva (CTVA) gained 3% on JPMorgan upgrade.